-

Nasal Sprays Help Alleviate Nasal Congestion

Xlear Statement on FDA Decongestant Decision

AMERICAN FORK, Utah--(BUSINESS WIRE)--Today, Nathan Jones, CEO of Xlear Inc., a consumer hygiene products company, released this statement regarding the FDA’s proposal to remove popular over-the-counter decongestants, which contain the drug phenylephrine, from the market:

“With the FDA concluding that this common decongestant isn’t effective, as we enter cold and flu season, and as families prepare to celebrate the holidays, many Americans need a new answer for the discomfort of sinus congestion,” Jones noted. “For people looking for help, the U.S. Centers for Disease Control (CDC) Guidance, ‘Relief for Symptoms of Colds and Coughs’, ‘instructions’ say to ‘use saline nasal spray to relieve congestion.’i Similarly, CDC’s ‘Sinus Infection Basics’ say ‘How to Feel Better’ ‘use a . . . saline nasal spray,’”ii he pointed out.

“You experience congestion because there is an irritant or pathogen in your upper airway that your body is trying to trap and wash away—your runny nose is your body flushing it out. Saline-based nasal sprays can help speed up that flushing, reduce pathogen load, and make it more effective. It’s commonsense: The faster the bad stuff is gone, the faster you feel better,” Jones added.

“For congestion caused by pathogens—like colds and flus—people can enhance that effect by using a nasal spray that contains xylitol. A series of studies show xylitol (a natural sugar) deactivates and/or blocks the adhesion of many types of viruses and bacteria, to your airway cells,”iii Jones continued. Adhesion is the process by which a pathogen attaches to your tissue to initiate infection. Using a nasal spray with xylitol helps block adhesion of these pathogens. For example, a Randomized Controlled (clinical) Trial published in 2022, determined that a saline-nasal spray containing xylitol and other ingredients reduced the rate of COVID-19 infections by 62 percent above placebo.iv

“Using a basic saline would be comparable to rinsing your hands with water; using a nasal spray with xylitol, like Xlear, would be comparable to washing your hands with soap. Expect more from your nasal hygiene products. Make sure they have xylitol so you can better and faster clean out the bad stuff while alleviating the congestion,” Jones added.

Xlear nasal spray is a saline-based nasal spray containing xylitol. Xlear 12 Hour Nasal Decongestant is a saline-based nasal spray containing xylitol and the decongestant Oxymetazoline HCL.

For more information on Xlear please visit www.xlear.com.

____________________________

i

https://www.cdc.gov/antibiotic-use/media/pdfs/HCP-Relief-Colds-Cough-85by11-P.pdf

ii

https://www.cdc.gov/sinus-infection/about/index.html

iii

For example: T Kontiokari, M Uhari, M Koskela, Antiadhesive effects of xylitol on otopathogenic bacteria., Journal of Antimicrobial Chemotherapy, Volume 41, Issue 5, May 1998, Pages 563–565, https://academic.oup.com/jac/article-abstract/41/5/563/652694?redirectedFrom=fulltext - google_vignette; Kontiokari, T., Uhari, M., & Koskela, M. (1998). Antiadhesive effects of xylitol on otopathogenic bacteria. The Journal of Antimicrobial Chemotherapy, 41(5), 563–565, https://academic.oup.com/jac/article-abstract/41/5/563/652694?redirectedFrom=fulltext&login=false; Jung, Kie Hoon. (2021). Antiviral Efficacy Against Virus Infections in Human-Derived Tracheal/Bronchial Epithelial Cells. Utah State University, https://xlrtmp.com/wp-content/uploads/2023/05/Antiviral-efficacy_USU2021.pdf; Vega, J. C., et al., (2020). Iota carrageenan and xylitol inhibit SARS-CoV-2 in Vero cell culture. BioRxiv, https://professionals.xlear.com/portfolio/anti-adherence-of-viruses/; Ruiz, V., Rodríguez-Cerrato, V., Huelves, L. et al. Adherence of Streptococcus pneumoniae to Polystyrene Plates and Epithelial Cells and the Antiadhesive Potential of Albumin and Xylitol. Pediatr Res 69, 23–27, https://www.nature.com/articles/pr920116 - citeas.

iv

Damian Balmforth, et al., Evaluating the efficacy and safety of a novel prophylactic nasal spray in the prevention of SARS-CoV-2 infection: A multi-centre, double blind, placebo-controlled, randomised trial., Journal of Clinical Virology, 155; 2022, https://www.sciencedirect.com/science/article/pii/S1386653222001809.

 

Contacts

Guillermo Meneses
202-445-1570
gm@nuciglo.com

Xlear Inc.


Release Summary
Nasal Sprays Help Alleviate Nasal Congestion; Xlear Statement on FDA Decongestant Decision
Release Versions

Contacts

Guillermo Meneses
202-445-1570
gm@nuciglo.com

Social Media Profiles
More News From Xlear Inc.

Xlear Sues FTC for Unlawful Scientific Censorship

SALT LAKE CITY--(BUSINESS WIRE)--Xlear Sues FTC for Unlawful Scientific Censorship; FTC’s marketing substantiation rules violate Supreme Court Loper Ruling...

Xlear, Inc. Commends Utah for its Leadership Role in Being the First State in the Nation to Ban Fluoride from its Public Drinking Water

AMERICAN FORK, Utah--(BUSINESS WIRE)--Nathan Jones, CEO of Xlear, Inc. a Utah-based leading natural health products company, issues the following statement. “As CEO of Xlear, Inc., and a keen proponent of eliminating fluoride from public drinking water, I congratulate Utah’s historic decision to become the first state to ban the addition of fluoride to its public and residential water systems. "The passing of HB0081 by the Utah legislature represents a pivotal moment for health freedom and indi...

DOJ Asks Court to Dismiss FTC-Xlear Lawsuit

AMERICAN FORK, Utah--(BUSINESS WIRE)--DOJ ASKS COURT TO DISMISS FTC-XLEAR LAWSUIT; Calls into Question FTC’s Authority to Require Clinical Studies for Non-Pharmaceutical Health Products...
Back to Newsroom